🤩 Kicking off 2024 with positive news in the world of Pharmacovigilance with the promising outcomes in a Kidney Disease Trial! 💊 The study’s findings revealed that half of the participants treated had a clinically meaningful reduction by 30% or more in albuminuria. 🌍 The results of this study will help to inform a Phase 3 clinical trial and will be evaluated in 11,000 patient participants worldwide. #pharmacovigilance #drugsafety #clinicaltrial #phase2 #research https://lnkd.in/eVVsbufN
